earnings

Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Endpoints
Roche
earnings
biosimilars
Flag link:
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Forbes
Abbott Labs
COVID-19
earnings
diagnostics
Flag link:
How Johnson & Johnson Beat Expectations in Q1
How Johnson & Johnson Beat Expectations in Q1
Motley Fool
JNJ
earnings
COVID-19
vaccines
Flag link:
6 medtechs to watch when earnings kick off next week
6 medtechs to watch when earnings kick off next week
Medtech Dive
earnings
devices
Abbott Labs
Edwards Lifesciences
Intuitive Surgical
JNJ
Roche
Quest Diagnostics
Flag link:
BioNTech's Q4 Results Wowed but Were Just the Tip of the Iceberg
BioNTech's Q4 Results Wowed but Were Just the Tip of the Iceberg
Motley Fool
BioNTech
earnings
vaccines
COVID-19
Pfizer
Flag link:
These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech
These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech
Motley Fool
Novavax
earnings
Flag link:
Medtech’s haves and have-nots
Medtech’s haves and have-nots
EP Vantage
earnings
devices
Medtech
Medtronic
EXACT Sciences
Thermo Fisher
Abbott Labs
Roche
Qiagen
JNJ
Zimmer Biomet
Smith & Nephew
Boston Scientific
Flag link:
Medtronic Gains Momentum in Diabetes
Medtronic Gains Momentum in Diabetes
Medical Devices and Diagnostics Industry
Medtronic
earnings
devices
diabetes
Flag link:
Here's What I'll Be Looking for in Moderna's Earnings Report Next Week
Here's What I'll Be Looking for in Moderna's Earnings Report Next Week
Motley Fool
Moderna Therapeutics
earnings
Flag link:
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
Flag link:
GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4
GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4
Motley Fool
GW Pharma
earnings
Flag link:
Exact Sciences Falls in After-Hours Trading on Q4 Results
Exact Sciences Falls in After-Hours Trading on Q4 Results
Motley Fool
EXACT Sciences
earnings
Flag link:
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Yahoo/Benzinga
earnings
FDA
G1 Therapeutics
trilaciclib
Zoetis
EXACT Sciences
Blueprint Medicines
Ironwood Pharmaceuticals
Flag link:
3 Q4 takeaways: COVID-19 testing strong (for now), electives hit, and M&A
3 Q4 takeaways: COVID-19 testing strong (for now), electives hit, and M&A
Medtech Dive
devices
earnings
COVID-19
pandemic
Flag link:
Why Alkermes' Q4 Results Were Better Than They Might Seem
Why Alkermes' Q4 Results Were Better Than They Might Seem
Motley Fool
Alkermes
earnings
Flag link:
How Pacific Biosciences Beat Expectations in Q4
How Pacific Biosciences Beat Expectations in Q4
Motley Fool
Pacific Biosciences
earnings
Flag link:
What's Behind Incyte's Better-Than-Expected Q4 Earnings
What's Behind Incyte's Better-Than-Expected Q4 Earnings
Motley Fool
Incyte
earnings
Flag link:
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Endpoints
Sanofi
earnings
Parkinson's Disease
drug development
Flag link:
Veklury rescues Gilead from COVID doldrums in Q4
Veklury rescues Gilead from COVID doldrums in Q4
Pharmaforum
Gilead Sciences
Veklury
earnings
Flag link:
Coronavirus uncertainty clouds Quest's 2d half amid Q4 revenue bump
Coronavirus uncertainty clouds Quest's 2d half amid Q4 revenue bump
Medtech Dive
Quest Diagnostics
diagnostics
earnings
COVID-19
Flag link:

Pages